Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

A patient lost all their hair while on rheumatoid arthritis medication.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Anti-CD19 therapy may help treat SLE and NMOSD.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

The FDA approved a new Pfizer drug for hair loss in teens.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.